[
    "{\"step_by_step_thinking\": \"Anti-D prophylaxis is given to Rh-negative women to prevent RhD alloimmunization, which can lead to hemolytic disease of the fetus and newborn. It is typically administered after any event that could lead to fetomaternal hemorrhage, such as amniocentesis, manual removal of placenta, and intra-uterine transfusion. However, MTP (Medical Termination of Pregnancy) at 63 days is an early stage of pregnancy where the risk of RhD alloimmunization is low, and hence, Anti-D prophylaxis is not typically administered.\", \"answer_choice\": \"A\"}"
]